Publikationen (38) Publikationen von DANIEL MORALES CANO

2024

  1. Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes

    Nature Cardiovascular Research, Vol. 3, Núm. 2, pp. 203-220

  2. Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human

    Vascular Pharmacology, Vol. 155

2023

  1. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  2. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

  3. Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension

    American Journal of Respiratory Cell and Molecular Biology, Vol. 69, Núm. 2, pp. 147-158

  4. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities

    PLoS pathogens, Vol. 19, Núm. 1, pp. e1011063

  5. The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit

    Biomedicine and Pharmacotherapy, Vol. 164

  6. Topography of immune cell infiltration in different stages of coronary atherosclerosis revealed by multiplex immunohistochemistry

    IJC Heart and Vasculature, Vol. 44

2022

  1. HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape

    Cells, Vol. 11, Núm. 15

2021

  1. Fibrous Caps in Atherosclerosis Form by Notch-Dependent Mechanisms Common to Arterial Media Development

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 41, Núm. 9, pp. E427-E439

  2. Oxygen-sensitivity and pulmonary selectivity of vasodilators as potential drugs for pulmonary hypertension

    Antioxidants, Vol. 10, Núm. 2, pp. 1-14

  3. Restoration of vitamin d levels improves endothelial function and increases task-like k+ currents in pulmonary arterial hypertension associated with vitamin d deficiency

    Biomolecules, Vol. 11, Núm. 6

2020

  1. Spontaneous Pulmonary Hypertension Associated With Systemic Sclerosis in P-Selectin Glycoprotein Ligand 1–Deficient Mice

    Arthritis and Rheumatology, Vol. 72, Núm. 3, pp. 477-487

  2. Uncovered Contribution of Kv7 Channels to Pulmonary Vascular Tone in Pulmonary Arterial Hypertension

    Hypertension, Vol. 76, Núm. 4, pp. 1134-1146

  3. Vitamin D deficiency downregulates TASK-1 channels and induces pulmonary vascular dysfunction

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 319, Núm. 4, pp. L627-L640

2019

  1. Activation of Kv7 channels as a novel mechanism for NO/cGMP-induced pulmonary vasodilation

    British Journal of Pharmacology, Vol. 176, Núm. 13, pp. 2131-2145

  2. Dietary Cocoa Prevents Aortic Remodeling and Vascular Oxidative Stress in Diabetic Rats

    Molecular Nutrition and Food Research, Vol. 63, Núm. 18

  3. Elevated pulmonary arterial pressure in Zucker diabetic fatty rats

    PLoS ONE, Vol. 14, Núm. 1

  4. Low ERA expression might be implicated in the development of pulmonary hypertensionin female mice lacking PSGL-1

    Annual European Congress of Rheumatology 2019

  5. Th2 CD4+ T Cells Are Necessary and Sufficient for Schistosoma-Pulmonary Hypertension

    Journal of the American Heart Association, Vol. 8, Núm. 15, pp. e013111